Clinical trials recruiting for Ischemic Stroke
17
Recruiting trials
3
US states with sites
23
Countries
6%
Accept healthy volunteers
Phase breakdown
Phase 2 1Phase 3 1Phase 4 2Not applicable 13
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Delayed anticoagulation | 2 |
| Early anticoagulation | 2 |
| Apixaban | 1 |
| Aspirin | 1 |
| DOAC | 1 |
| NOAC | 1 |
| Statin monotherapy (rosuvastatin or atorvastatin) | 1 |
| statin + ezetimibe | 1 |
| thrombolysis therapy | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Maryland | 2 |
| Kentucky | 1 |
| Ohio | 1 |
Top cities
Self-screener
Recruiting trials
- Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants
- Augmented Renal Clearance in Neurocritical Care
- Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
- Cerebral Embolization During Pulmonary Vein Isolation
- Cerebrospinal Fluid Mitochondrial Biomarkers in Ischemic Stroke and Alzheimer Disease
- Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
- Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
- Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke
- Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline
- Imaging the Pathogenesis of Cerebral Small Vessel Disease
- Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy
- Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation
- Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation
- The Southern-Norway Post-Stroke Atrial Fibrillation Study
- Thrombolysis in Factor Xa-inhibitors Trial
- Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
- Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
Related conditions
Trials recruiting for Ischemic Stroke often also study these conditions. Each links to its own recruiting-trial list.
Atrial fibrillation 535Stroke 94Atrial Fibrillation (AF) 126Hypertension 1201Alzheimer's disease 617Vascular Diseases 18Transient Ischemic Attack 4TBI (Traumatic Brain Injury) 5Subarachnoid Hemorrhage, Aneurysmal 3Stroke (in Patients With Atrial Fibrillation) 4
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Ischemic Stroke trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.